$COSMOS PHARMACEUTICAL CORP (CSMYF.US)$The financial report will be released on April 12, so investors stay tuned.
What was the previous performance?
$COSMOS PHARMACEUTICAL CORP (CSMYF.US)$2024/Q2 operating income was 234.777 billion yen, net profit was 5,079 billion yen, and earnings per share were 128.18 yen.
2023/Q3 operating income was 202.286 billion yen, net profit was 4.984 billion yen, and earnings per share were 125.86,2034 yen.
Futubull tips:
1. There is no hard rule on the division of the fiscal year for Hong Kong stock and US stock listed companies; it is entirely up to the enterprise to decide. Therefore, each financial reporting period can be used as the enterprise's annual report deadline, rather than the natural year as the fiscal year.
2. Generally speaking, the company will hold a financial report meeting on or near the above financial report release date. At that time, the company management will discuss and explain the latest quarter's financial data and operations, and communicate with investors, analysts, media, etc.
Investors can participate through offline meetings or online conference calls.